Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitaxsentan sodium in pulmonary arterial hypertension
NCT00080457Phase 3Completed
- Sponsor
- Encysive Pharmaceuticals Inc.
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitaxsentan in pulmonary arterial hypertension (PAH), sponsored by Encysive Pharmaceuticals Inc.. Started May 2003; status: completed.
02
Drugs
sitaxsentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00080457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080457.